Pediatric acute flaccid myelitis: Evaluation of diagnostic criteria and differentiation from other causes of acute flaccid paralysis.
暂无分享,去创建一个
H. Braakman | A. Meijer | O. Brouwer | H. Niesters | L. Sie | B. Jacobs | E. Niks | J. Niermeijer | V. Roelfsema | K. Benschop | R. Neuteboom | R. Brandsma | C. van Leer-Buter | D. P. Bakker | M. D. de Lange | N. Schoenmaker | M. T. te Wierik | J. Helfferich | E. de Bie
[1] H. Braakman,et al. Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[2] C. Sadowsky,et al. Challenges in the clinical recognition of acute flaccid myelitis and its implications. , 2022, Jornal de Pediatria.
[3] K. Tyler,et al. Neutralizing Antibody Given after Paralysis Onset Reduces the Severity of Paralysis Compared to Nonspecific Antibody-Treated Controls in a Mouse Model of EV-D68-Associated Acute Flaccid Myelitis , 2022, Antimicrobial agents and chemotherapy.
[4] J. Crowe,et al. Enterovirus D68 in the Anterior Horn Cells of a Child with Acute Flaccid Myelitis. , 2022, The New England journal of medicine.
[5] R. Tasker. Rapid Onset of Neuromuscular Paralysis or Weakness. , 2022, Critical care clinics.
[6] E. Tiongson,et al. Does acute flaccid myelitis cause respiratory failure in children? , 2021, Pediatric pulmonology.
[7] O. Brouwer,et al. Acute flaccid myelitis and Guillain–Barré syndrome in children: A comparative study with evaluation of diagnostic criteria , 2021, European journal of neurology.
[8] R. Prayson,et al. Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: Red flags for false positivity , 2021, Journal of Neuroimmunology.
[9] Eliza M. Gordon-Lipkin,et al. Acute flaccid myelitis: cause, diagnosis, and management , 2020, The Lancet.
[10] C. Lechner,et al. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. , 2020, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[11] E. Yeh,et al. Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis , 2020, Frontiers in Pediatrics.
[12] K. Tyler,et al. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. , 2019, The Lancet. Infectious diseases.
[13] J. Brenton,et al. Acute Transverse and Flaccid Myelitis in Children , 2019, Current Treatment Options in Neurology.
[14] L. Meiners,et al. Acute flaccid myelitis and enterovirus D68: lessons from the past and present , 2019, European Journal of Pediatrics.
[15] H. Mori,et al. Serial MRI findings of acute flaccid myelitis during an outbreak of enterovirus D68 infection in Japan , 2019, Brain and Development.
[16] B. Lina,et al. Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice. , 2019, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[17] O. Brouwer,et al. Twenty-nine Cases of Enterovirus-D68–associated Acute Flaccid Myelitis in Europe 2016 , 2018, The Pediatric infectious disease journal.
[18] Eliza M. Gordon-Lipkin,et al. Clinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016 , 2019, JAMA pediatrics.
[19] K. Tyler,et al. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. , 2018, The Lancet. Infectious diseases.
[20] P. Horby,et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. , 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[21] T. Shiihara,et al. Clinical Features of Acute Flaccid Myelitis Temporally Associated With an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August–December 2015 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] K. Tyler,et al. Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68–Associated Paralytic Myelitis , 2017, The Journal of infectious diseases.
[23] K. Tyler,et al. Outcomes of Colorado children with acute flaccid myelitis at 1 year , 2017, Neurology.
[24] C. Catsman-Berrevoets,et al. Diagnosis of Guillain–Barré syndrome in children and validation of the Brighton criteria , 2017, Journal of Neurology.
[25] K. Tyler,et al. A mouse model of paralytic myelitis caused by enterovirus D68 , 2017, PLoS pathogens.
[26] K. Tyler,et al. Acute flaccid myelitis: A clinical review of US cases 2012–2015 , 2016, Annals of neurology.
[27] C. Lucchinetti,et al. Acute disseminated encephalomyelitis , 2016, Neurology.
[28] K. Deiva,et al. Pediatric transverse myelitis , 2016, Neurology.
[29] N. Stence,et al. MRI Findings in Children with Acute Flaccid Paralysis and Cranial Nerve Dysfunction Occurring during the 2014 Enterovirus D68 Outbreak , 2015, American Journal of Neuroradiology.
[30] Suvasini Sharma,et al. Midbrain and Spinal Cord Magnetic Resonance Imaging (MRI) Changes in Poliomyelitis , 2010, Journal of child neurology.
[31] L. Morrison,et al. Proposed diagnostic criteria and nosology of acute transverse myelitis , 2003 .
[32] H. Hartung,et al. Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome , 1998, Annals of neurology.